Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 46 citing articles:

Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Renqing Zhao
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 17
The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury
Eslam E. Abd El-Fattah, Sameh Saber, Ahmed A.E. Mourad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112628-112628
Open Access | Times Cited: 57
Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control
Mahmoud E. Youssef, Galal Yahya, Mihaela Simona Popoviciu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6039-6039
Open Access | Times Cited: 36
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Lobna A. Saleh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1123-1123
Open Access | Times Cited: 30
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E. Abd El-Fattah, A. M. Abdelhamid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114196-114196
Open Access | Times Cited: 23
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
Rasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel‐Reheim, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis
Mohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113409-113409
Closed Access | Times Cited: 35
Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples
Boxun Zhang, Ke Liu, Haoyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 32
Ambroxol, a mucolytic agent, boosts HO‐1, suppresses NF‐κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
Simona Cavalu, Hossam Sharaf, Sameh Saber, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 32
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need
Mona H. Zohny, Simona Cavalu, Mahmoud E. Youssef, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112723-112723
Open Access | Times Cited: 29
Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach
Sameh Saber, Alexandru Madalin Hasan, Osama A. Mohammed, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114918-114918
Open Access | Times Cited: 18
Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors
Mona Mashayekhi, Bilgunay Ilkin Safa, Matthew S.C. Gonzalez, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 425-438
Closed Access | Times Cited: 5
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
A. M. Abdelhamid, Sameh Saber, Mahmoud E. Youssef, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112455-112455
Open Access | Times Cited: 40
Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung
Eslam E. Abd El-Fattah, A. M. Abdelhamid
Toxicology (2021) Vol. 463, pp. 152994-152994
Closed Access | Times Cited: 37
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis
A. M. Abdelhamid, Mahmoud E. Youssef, Simona Cavalu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA
Nahid Alimoradi, Mohammad Tahami, Negar Firouzabadi, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 15
Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis
Ahmed S. Saad, Rachel Michel, Mostafa A. Borahay
Current Nutrition Reports (2024) Vol. 13, Iss. 3, pp. 557-565
Closed Access | Times Cited: 4
Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
Run Cao, Jing Jing, Yuting Ma, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1773-1786
Open Access
Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access
NLRP3 inflammasomes pathway: a key target for Metformin
Yasamin Hosseini, Amirhossein Niknejad, Ayeh Sabbagh Kashani, et al.
Inflammopharmacology (2025)
Closed Access
Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic
Wasuwit Wanchaitanawong, Nithi Thinrungroj, Siriporn C. Chattipakorn, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109230-109230
Closed Access | Times Cited: 21
Metformin Inhibits NLR Family Pyrin Domain Containing 3 (NLRP)-Relevant Neuroinflammation via an Adenosine-5′-Monophosphate-Activated Protein Kinase (AMPK)-Dependent Pathway to Alleviate Early Brain Injury After Subarachnoid Hemorrhage in Mice
Lei Jin, Fa Jin, Shenquan Guo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway
Yajiang Yuan, Xiangyi Fan, Zhanpeng Guo, et al.
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 19
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis
Ahmed A. Shaaban, A. M. Abdelhamid, Mohamed M.Y. Kaddah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113247-113247
Closed Access | Times Cited: 19
Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
Eslam E. Abd El-Fattah, Amr Y. Zakaria
International Immunopharmacology (2022) Vol. 109, pp. 108889-108889
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top